Eci Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Eci Pharmaceuticals

Access the complete profile.

Eci Pharmaceuticals Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 44611 Pharmacies & Drug Stores
Address	5311 Nw 35th Terrace Fort Lauderdale, FL 33309

Note: Revenues for privately held companies are statistical evaluations.


Eci Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Eci Pharmaceuticals's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Eci Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Eci Pharmaceuticals Annual Revenue and Growth Rate

Eci Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Eci Pharmaceuticals's revenues are gauged from an analysis of company filings.

Eci Pharmaceuticals's Income Statement (based on Industry Averages)

Eci Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Eci Pharmaceuticals is developing and marketing. Eci Pharmaceuticals doesn't have any recent trademark applications, indicating Eci Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PREXXARTAN Pharmaceutical preparations for the prevention of disorders of the cardiovascular system; Pharmaceutical preparations for the treatment of disorders of the cardiovascular system	03/24/2022

See all trademarks and details in the Full Report.

Market Share of Eci Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Eci Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Eci Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
VITAL PHARMACEUTICALS	Weston, FL	100
ARNET PHARMACEUTICAL	Davie, FL	65
BIOMATRIX SPECIALTY PHARMACY	Plantation, FL	27
UNIPHARMA	Tamarac, FL	23
CLINICAL DIAGNOSTIC SOLUTIONS	Plantation, FL	15
NEW VISION PHARMACEUTICALS	Tamarac, FL	11

Future Competition: Eci Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Eci Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)